 by the FFBI, every new autogenous access
should be evaluated for development at 4 weeks. If the
access is not adequately maturing by four weeks or not
functional by 12 weeks (ie, access flow ‚¨ç500 ml/min, a
recirculation higher than 10%, or inability to cannulate), a
contrast study should be performed. Beathard et al112
demonstrated the feasibility of salvage of the